Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 372 (9648), 1502-17

Multiple Sclerosis


Multiple Sclerosis

Alastair Compston et al. Lancet.


Multiple sclerosis is primarily an inflammatory disorder of the brain and spinal cord in which focal lymphocytic infiltration leads to damage of myelin and axons. Initially, inflammation is transient and remyelination occurs but is not durable. Hence, the early course of disease is characterised by episodes of neurological dysfunction that usually recover. However, over time the pathological changes become dominated by widespread microglial activation associated with extensive and chronic neurodegeneration, the clinical correlate of which is progressive accumulation of disability. Paraclinical investigations show abnormalities that indicate the distribution of inflammatory lesions and axonal loss (MRI); interference of conduction in previously myelinated pathways (evoked electrophysiological potentials); and intrathecal synthesis of oligoclonal antibody (examination by lumbar puncture of the cerebrospinal fluid). Multiple sclerosis is triggered by environmental factors in individuals with complex genetic-risk profiles. Licensed disease modifying agents reduce the frequency of new episodes but do not reverse fixed deficits and have questionable effects on the long-term accumulation of disability and disease progression. We anticipate that future studies in multiple sclerosis will provide a new taxonomy on the basis of mechanisms rather than clinical empiricism, and so inform strategies for improved treatment at all stages of the disease.

Similar articles

  • Neuronal Injury in Chronic CNS Inflammation
    E Zindler et al. Best Pract Res Clin Anaesthesiol 24 (4), 551-62. PMID 21619866. - Review
    Currently, Glatiramer acetate (GA) and the interferon-β (IFN-β) variants are established as first-line disease modifying treatments that reduce the relapse rate, ameliora …
  • Changes in the Expression and Localization of the Paranodal Protein Caspr on Axons in Chronic Multiple Sclerosis
    G Wolswijk et al. Brain 126 (Pt 7), 1638-49. PMID 12805111.
    The presence of intact paranodal junctions on myelinated axons in the CNS and PNS is crucial for both myelin sheath attachment and saltatory impulse conduction. The axona …
  • Pathogenesis of Brain and Spinal Cord Atrophy in Multiple Sclerosis
    A Minagar et al. J Neuroimaging 14 (3 Suppl), 5S-10S. PMID 15228754. - Review
    For more than a century, multiple sclerosis was viewed as a disease process characterized by oligodendrocyte and myelin loss, and research into the pathogenesis of multip …
  • [Multiple Sclerosis: A Degenerative Disease?]
    C Confavreux et al. Bull Acad Natl Med 192 (3), 483-91; discussion 492-3. PMID 18819694. - Review
    Multiple sclerosis (MS) is an organ-specific autoimmune disease targeting central nervous system myelin. The clinical course results from an interplay between relapses an …
  • The Basis for Treatment in Multiple Sclerosis
    A Compston. Acta Neurol Scand Suppl 183, 41-7. PMID 16637928. - Review
    Contemporary licensed treatments for multiple sclerosis fail to provide a solution for the disease because their effects are limited to a modest reduction in the frequenc …
See all similar articles

Cited by 1,158 PubMed Central articles

See all "Cited by" articles

Publication types